Scarica l'app Stockscreener
34.73
1.11%
-0.39
Dopo l'orario di chiusura:
34.00
-0.73
-2.10%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VKTX Giù?
Forum
Previsione
Precedente Chiudi:
$35.12
Aprire:
$35.55
Volume 24 ore:
4.47M
Relative Volume:
0.71
Capitalizzazione di mercato:
$3.91B
Reddito:
-
Utile/perdita netta:
$-99.15M
Rapporto P/E:
-37.34
EPS:
-0.93
Flusso di cassa netto:
$-74.25M
1 W Prestazione:
-0.71%
1M Prestazione:
+46.60%
6M Prestazione:
+47.16%
1 anno Prestazione:
-47.26%
Intervallo 1D:
$34.16
$36.80
Intervallo di 1 settimana:
$32.21
$36.80
Portata 52W:
$18.92
$81.73
Viking Therapeutics Inc Stock (VKTX) Company Profile
Nome
Viking Therapeutics Inc
Settore
Industria
Telefono
858-704-4660
Indirizzo
9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
Confronta VKTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VKTX
Viking Therapeutics Inc
|
34.73 | 3.72B | 0 | -99.15M | -74.25M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Viking Therapeutics Inc Stock (VKTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Iniziato | Goldman | Neutral |
| 2025-02-13 | Iniziato | Scotiabank | Sector Outperform |
| 2025-02-07 | Iniziato | Citigroup | Neutral |
| 2024-12-02 | Iniziato | Piper Sandler | Overweight |
| 2024-11-22 | Iniziato | B. Riley Securities | Buy |
| 2024-11-04 | Reiterato | H.C. Wainwright | Buy |
| 2024-09-11 | Iniziato | JP Morgan | Overweight |
| 2024-06-27 | Iniziato | Morgan Stanley | Overweight |
| 2024-05-16 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-03-26 | Reiterato | Oppenheimer | Outperform |
| 2024-03-07 | Iniziato | Jefferies | Buy |
| 2024-02-28 | Reiterato | Oppenheimer | Outperform |
| 2023-05-31 | Ripresa | ROTH MKM | Buy |
| 2023-03-28 | Reiterato | Maxim Group | Buy |
| 2023-03-17 | Iniziato | Stifel | Buy |
| 2021-07-29 | Ripresa | BTIG Research | Buy |
| 2021-05-25 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2020-06-05 | Iniziato | BMO Capital Markets | Outperform |
| 2020-05-05 | Iniziato | Chardan Capital Markets | Buy |
| 2020-05-01 | Iniziato | BTIG Research | Buy |
| 2019-07-16 | Iniziato | Oppenheimer | Outperform |
| 2019-06-25 | Iniziato | Stifel | Buy |
| 2019-03-29 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2019-03-14 | Reiterato | Maxim Group | Buy |
| 2019-02-22 | Iniziato | SVB Leerink | Mkt Perform |
| 2018-12-12 | Iniziato | B. Riley FBR | Buy |
| 2018-11-19 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-09-18 | Reiterato | H.C. Wainwright | Buy |
| 2018-09-18 | Reiterato | Maxim Group | Buy |
| 2018-09-18 | Reiterato | Raymond James | Outperform |
| 2018-07-20 | Iniziato | SunTrust | Buy |
| 2018-06-28 | Iniziato | Raymond James | Outperform |
| 2018-06-01 | Reiterato | Laidlaw | Buy |
| 2018-05-31 | Reiterato | Maxim Group | Buy |
| 2018-03-26 | Ripresa | H.C. Wainwright | Buy |
| 2017-11-28 | Reiterato | Maxim Group | Buy |
| 2017-11-21 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Viking Therapeutics Inc Borsa (VKTX) Ultime notizie
How hedge fund analytics apply to Viking Therapeutics Inc. stockRecession Risk & Safe Capital Investment Plans - newser.com
Viking Therapeutics (VKTX): Assessing Valuation as VK2735 Advances Through Late-Stage Obesity Drug Trials - simplywall.st
Did Viking Therapeutics Just Say "Checkmate" to Eli Lilly? - The Motley Fool
Q3 2025 Results on Oct. 22 — Viking Therapeutics to Host Conference Call and Webcast - Stock Titan
Sector ETF performance correlation with Viking Therapeutics Inc.2025 Price Momentum & Low Risk Entry Point Guides - newser.com
How to build a custom watchlist for Viking Therapeutics Inc.Oil Prices & Consistent Growth Equity Picks - newser.com
Is a relief rally coming for Viking Therapeutics Inc. holdersNew Guidance & AI Powered Market Trend Analysis - newser.com
Live market analysis of Viking Therapeutics Inc.2025 Technical Overview & Weekly Watchlist for Hot Stocks - newser.com
Can Viking Therapeutics Inc. stock hit record highs againJuly 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - newser.com
Using data models to predict Viking Therapeutics Inc. stock movement2025 Trading Recap & Reliable Volume Spike Trade Alerts - newser.com
How to integrate Viking Therapeutics Inc. into portfolio analysis toolsQuarterly Portfolio Report & Advanced Swing Trade Entry Plans - newser.com
Visualizing Viking Therapeutics Inc. stock with heatmapsJuly 2025 Fed Impact & Verified Swing Trading Watchlist - newser.com
Will Progress in VK2735 Weight Loss Trials Change Viking Therapeutics' (VKTX) Narrative? - simplywall.st
Chart based exit strategy for Viking Therapeutics Inc.Portfolio Update Report & Weekly Setup with High ROI Potential - newser.com
Why Shares in Viking Therapeutics Surged This Week - MSN
Viking Therapeutics, Inc. (VKTX) Registers a Bigger Fall Than the Market: Important Facts to Note - sharewise.com
Earnings call transcript: Viking Therapeutics Q2 2025 sees increased R&D expenses - Investing.com
What makes Viking Therapeutics Inc. stock attractive to growth fundsJuly 2025 News Drivers & Proven Capital Preservation Tips - newser.com
Down 44%, Should You Buy the Dip on Viking Therapeutics? - sharewise.com
Why Viking Therapeutics Inc. stock attracts high net worth investors2025 Valuation Update & Safe Capital Growth Stock Tips - newser.com
Key metrics from Viking Therapeutics Inc.’s quarterly dataWeekly Gains Summary & Long-Term Capital Growth Ideas - newser.com
Can trapped investors hope for a rebound in Viking Therapeutics Inc.Exit Point & High Accuracy Buy Signal Tips - newser.com
Is Viking Therapeutics Inc. stock oversold or undervaluedQuarterly Profit Review & AI Powered Market Entry Ideas - newser.com
Viking Therapeutics Inc. stock volume spike explained2025 Market Sentiment & Community Driven Trade Alerts - newser.com
VKTX stock tumbles 29% today — Viking Therapeutics weight-loss trial results fuel massive investor sell-off and market jitters - MSN
Viking Therapeutics, Inc. $VKTX Shares Acquired by Blair William & Co. IL - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Shares Down 4.1%What's Next? - MarketBeat
Will a bounce in Viking Therapeutics Inc. offer an exitJuly 2025 Intraday Action & Daily Profit Focused Screening - newser.com
Why Akero Therapeutics Stock Trounced the Market on Thursday - AOL.com
Wealth Enhancement Advisory Services LLC Purchases New Stake in Viking Therapeutics, Inc. $VKTX - MarketBeat
Analyzing Viking Therapeutics Inc. with risk reward ratio charts2025 Price Action Summary & Verified Momentum Stock Ideas - newser.com
Viking Therapeutics (NASDAQ:VKTX) Stock Price Up 8.1%Should You Buy? - MarketBeat
Viking Therapeutics Inc Azioni (VKTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Viking Therapeutics Inc Azioni (VKTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| ZANTE GREG | Chief Financial Officer |
Jul 03 '25 |
Sale |
27.76 |
4,266 |
118,428 |
168,660 |
| Mancini Marianna | Chief Operating Officer |
Jul 03 '25 |
Sale |
27.77 |
4,266 |
118,473 |
377,535 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):